The irradiation conditions involve the exposure to C-ion beams; the treatment also included miRNA-34, a tumor suppressor miRNA that targets multiple oncogenic pathways, and rapamycin, an mTOR inhibitor, which is used to disrupt the mTOR signaling pathway commonly upregulated in cancer cells. Here, MTOR is linked to cancer.